Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marteau

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Physiopathology of Clostridium difficile-related intestinal disease. Role of the colonic ecosystem]P Marteau, I Sobhani, O Berretta, et al.
Gut|April 16, 1998
Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre studyP Marteau, J Crand, M Foucault, et al.
Alimentary Pharmacology & Therapeutics|December 1, 1996
Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in FranceP Marteau, F Nelet, M Le Lu, et al.
The Proceedings of the Nutrition Society|August 1, 1993
Manipulation of the human gut microfloraJ C Rambaud, Y Bouhnik, P Marteau, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Digestive gas: pathophysiology and therapeutic approach in functional bowel disorders]D Cloarec, B Florrié, P Marteau, et al.
World Review of Nutrition and Dietetics|January 1, 1993
The fate and effects of transiting, nonpathogenic microorganisms in the human intestineP Marteau, P Pochart, Y Bouhnik, et al.
Trends in Biotechnology|January 1, 1994
Establishing a scientific basis for probiotic R&DJ H Huis in't Veld, R Havenaar, P Marteau
Alimentary Pharmacology & Therapeutics|December 9, 1998
Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranulesP Marteau, R Tennenbaum, E Elefant, et al.
Digestive Diseases and Sciences|December 1, 1996
Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA)O Chazouillères, P Marteau, M Haniche, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1997
Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitisD Lucidarme, P Marteau, M Foucault, et al.
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Physiopathology of Clostridium difficile-related intestinal disease. Role of the colonic ecosystem]P Marteau, I Sobhani, O Berretta, et al.
Gut|April 16, 1998
Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre studyP Marteau, J Crand, M Foucault, et al.
Alimentary Pharmacology & Therapeutics|December 1, 1996
Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in FranceP Marteau, F Nelet, M Le Lu, et al.
The Proceedings of the Nutrition Society|August 1, 1993
Manipulation of the human gut microfloraJ C Rambaud, Y Bouhnik, P Marteau, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1990
[Digestive gas: pathophysiology and therapeutic approach in functional bowel disorders]D Cloarec, B Florrié, P Marteau, et al.
World Review of Nutrition and Dietetics|January 1, 1993
The fate and effects of transiting, nonpathogenic microorganisms in the human intestineP Marteau, P Pochart, Y Bouhnik, et al.
Trends in Biotechnology|January 1, 1994
Establishing a scientific basis for probiotic R&DJ H Huis in't Veld, R Havenaar, P Marteau
Alimentary Pharmacology & Therapeutics|December 9, 1998
Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranulesP Marteau, R Tennenbaum, E Elefant, et al.
Digestive Diseases and Sciences|December 1, 1996
Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA)O Chazouillères, P Marteau, M Haniche, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1997
Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitisD Lucidarme, P Marteau, M Foucault, et al.
Pageof 18